CAR-T Re-treatment for Refractory/Relapsed Multiple Myeloma

NCT03672253 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Multiple Myeloma in Relapse
Multiple Myeloma Progression

Interventions

DRUG: CAR-T Re-treatment

Sponsor

Second Affiliated Hospital of Xi'an Jiaotong University

Collaborators

[object Object]